Case Report: a rare case of small cell carcinoma of the prostate - Report - MDSpire

Case Report: a rare case of small cell carcinoma of the prostate

  • By

  • Kexin Geng

  • Feng Gao

  • June 8, 2026

  • 0 min

Share

Clinical Report: Uncommon Presentation of Small Cell Carcinoma in the Prostate

Overview

This report details a case of small cell carcinoma of the prostate in a 74-year-old man, highlighting the challenges of diagnosis due to normal PSA levels. The patient presented with defecation difficulties and imaging findings suggestive of malignancy, ultimately leading to a diagnosis confirmed by biopsy.

Background

Small cell carcinoma of the prostate (SCCP) is a rare and aggressive form of prostate cancer, accounting for 0.5%–2% of cases. Its non-specific symptoms and often normal prostate-specific antigen (PSA) levels complicate early diagnosis, leading to advanced disease at presentation. Understanding the clinical and radiological indicators for early biopsy is crucial for improving outcomes in affected patients.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Small cell carcinoma of the prostate is rare and aggressive, often presenting with normal PSA levels.
  • The case involved a 74-year-old man with progressive defecation difficulty and an enlarged prostate.
  • Imaging revealed a prostate mass suggestive of local invasion despite normal serum PSA levels.
  • Needle biopsy confirmed the diagnosis of small cell carcinoma with neuroendocrine marker expression.
  • The patient received chemotherapy but deteriorated rapidly and died shortly after treatment initiation.

Clinical Implications

Clinicians should maintain a high index of suspicion for small cell carcinoma in patients presenting with invasive-appearing prostate lesions, even when PSA levels are normal. Early biopsy is essential for accurate diagnosis and timely intervention.

Conclusion

Strengthen the conclusion by reiterating the urgency of prompt diagnostic procedures.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Small cell carcinoma in a bladder diverticulum: a rare case report and literature review
  2. the pathologist, 2026 -- New Marker for Aggressive Prostate Cancer
  3. Frontiers in Medicine, 2026 -- From persistent hypercalcemia to parathyroid carcinoma: a case report of acute urinary retention and the diagnostic role of Ki-67
  4. Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update | Journal of Clinical Oncology
  5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  6. conexiant — When Tuberculosis Mimics Prostate Cancer
  7. Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update | Journal of Clinical Oncology
  8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  9. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial - PMC

Original Source(s)

Related Content